Literature DB >> 19915512

Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach.

Alberto Berardi1, Licia Lugli, Dante Baronciani, Cecilia Rossi, Matilde Ciccia, Roberta Creti, Lucia Gambini, Sabrina Mariani, Irene Papa, Elisabetta Tridapalli, Federica Vagnarelli, Fabrizio Ferrari.   

Abstract

BACKGROUND: Group B Streptococcus (GBS) is a leading cause of neonatal bacterial infections. Early-onset infections have decreased in recent years but, despite considerable efforts poured into prevention, cases continue to occur.
OBJECTIVES: To analyze trends and identify determining factors for the persistence of the GBS infections. To evaluate the impact of antenatal screening and intrapartum chemoprophylaxis on the clinical presentation of the infection.
METHODS: A prospective cohort, population-based study has been ongoing in Emilia-Romagna (Italy) since 2003. Invasive GBS infections, observed between 2003 and 2008 in infants aged < 7 days were analyzed.
RESULTS: Among 214,120 live births, 61 early-infections were observed. Fourteen infants (23.0%) were born preterm. Among 47 infants who were delivered at term, 28 were born to mothers who had no risk factors and 7 were born to mothers who had none other than GBS colonization. Forty-one women at term had been screened prenatally; among them, only 10 were documented as GBS culture-positive.Disease severity was highest in infants at lower gestational ages, but most meningitis cases were observed in term infants born to mothers who were GBS culture-negative at screening.Nine newborns had culture-proven infection despite having received intrapartum antibiotics. They were born to mothers with > or =1 obstetrical risk factors and 5 mothers had been treated during labor with macrolides.
CONCLUSION: Most infections presented in infants whose mothers had been screened as GBS culture-negative. Missed opportunities for prevention contributed more than prophylaxis failures to the early-onset disease burden.

Entities:  

Mesh:

Year:  2010        PMID: 19915512     DOI: 10.1097/INF.0b013e3181b83cd9

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  6 in total

Review 1.  Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.

Authors:  J Rodriguez-Granger; J C Alvargonzalez; A Berardi; R Berner; M Kunze; M Hufnagel; P Melin; A Decheva; G Orefici; C Poyart; J Telford; A Efstratiou; M Killian; P Krizova; L Baldassarri; B Spellerberg; A Puertas; M Rosa-Fraile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09       Impact factor: 3.267

2.  Serial physical examinations, a simple and reliable tool for managing neonates at risk for early-onset sepsis.

Authors:  Alberto Berardi; Anna Maria Buffagni; Cecilia Rossi; Eleonora Vaccina; Chiara Cattelani; Lucia Gambini; Federica Baccilieri; Francesca Varioli; Fabrizio Ferrari
Journal:  World J Clin Pediatr       Date:  2016-11-08

3.  The prevalence and risk factors of group B streptococcus colonization in Iranian pregnant women.

Authors:  Roksana Darabi; Sima Tadi; Mitra Mohit; Erfan Sadeghi; Gita Hatamizadeh; Bahareh Kardeh; Mina Etminan-Bakhsh; Yekta Parsa
Journal:  Electron Physician       Date:  2017-05-25

4.  Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands.

Authors:  Diny G E Kolkman; Marlies E B Rijnders; Maurice G A J Wouters; M Elske van den Akker-van Marle; Cpb Kitty van der Ploeg; Christianne J M de Groot; Margot A H Fleuren
Journal:  BMC Pregnancy Childbirth       Date:  2013-07-30       Impact factor: 3.007

5.  Invasive Group B Streptococcal Disease in Neonates and Infants, Italy, Years 2015-2019.

Authors:  Roberta Creti; Monica Imperi; Alberto Berardi; Erika Lindh; Giovanna Alfarone; Marco Pataracchia; Simona Recchia
Journal:  Microorganisms       Date:  2021-12-13

Review 6.  Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.

Authors:  Anna Dobrut; Monika Brzychczy-Włoch
Journal:  Pathogens       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.